Immune-Onc Therapeutics - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

SLB and NVIDIA expand AI collaboration to industrialise energy-sector data infrastructure

Representative image of IBM's AI governance and security headquarters, where the watsonx.governance and Guardium AI Security platforms are reshaping compliance architecture for regulated industries.

IBM and ElevenLabs bring enterprise-grade voice AI to watsonx Orchestrate, targeting regulated sectors at scale

Representative image of United States President Donald Trump and oil tankers in the Strait of Hormuz, illustrating the story on Trump extending the Hormuz deadline again as United States-Iran indirect talks advance through Pakistan.

Trump extends Strait of Hormuz deadline for second time as US-Iran indirect talks advance through Pakistan

Representative image of financial growth metrics and capital allocation themes linked to Westaim Corporation’s Q4 2025 results, as investors assess Ceres Life Insurance Company’s annuity expansion and Arena Investors Group Holdings’ turnaround outlook.

Westaim (TSXV: WED) posts wider FY2025 loss as Ceres Life ramp and Arena reset reshape 2026 outlook

FDA Grants Orphan Drug Designation to Immune-Onc Therapeutics IO-202 for CMML Treatment

Read More

2 minute read

Pharma Industry News

Immune-Onc Therapeutics gets FDA orphan drug status for IO-202 in CMML

Immune-Onc Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the development of innovative therapies in immunology and oncology,…

byPallavi Madhiraju

February 22, 2024

web analytics